Saudi Med J
-
To evaluate the antibacterial activity of plumbagin (PGN) against multidrug resistance (MDR) clinical isolates. ⋯ Plumbagin is a stand-alone, broad spectrum antibacterial with promising potential against the rising threat of antimicrobial resistance.
-
To determine the prevalence of the metabolic syndrome (MetS) and its related risk factors in a group of healthy subjects. ⋯ Metabolic syndrome prevalence and defining criteria are significantly high among Iraqi university students. Fasting blood glucose was the most common component followed by increased WC. The significant risk factors for MetS were older age, females, high BMI (≥25), low physical-activity, and eating of fast foods, and can remedy the risk if the components of the disease are reported at a younger age.
-
To investigate the emergent mutations involved in the evolutionary stages of the virus for better management of pandemic. ⋯ The current study provides useful information for further experimental investigation of mutation's effects on virus transmission, severity, and vaccine efficacy.
-
To determine whether sevoflurane regulates cisplatin resistance in neuroblastoma cells. ⋯ Sevoflurane has great clinical potential against cisplatin-resistant tumors. Further animal experiments and clinical trials are required to achieve this goal.